AMAM   $10.56  -11.37% Market Open

Ambrx Biopharma Inc
Last Events:

2023-03-29 Trend pattern changed from расходящийся треугольник to симметричный треугольник.

2023-03-29 Signal in Stochastic changed from bullish to bearish weakening. The stochastic indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: main and signal line crossing.

2023-03-29 Signal in MACD changed from bullish weakening to bearish. Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: signal line crossed the middle level.

2023-03-29 Signal in RSI changed from bullish weakening to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-03-29 Signal in EMA100 changed from bullish reversal to bearish reversal. 2023-02-07 the price crossed down the moving average line and formed a short-term downside trend.

2023-03-29 Signal in EMA50 changed from bullish reversal to bearish reversal. 2023-02-07 the price crossed down the moving average line and formed a short-term downside trend.

2023-03-29 Signal in EMA20 changed from bullish reversal to bearish reversal. 2023-01-26 the price crossed down the moving average line and demonstrates a strong downside trend.

2023-03-29 Trend changed from down and flat to linear down.


Current temperature: 1.23
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 1.75
Target: 8.50
High with 50% probability: 16.08
Analyst Recommendations:
Number of estimates 2
Target Price Mean 8.50
Mean unverified/preliminary 8.50 / 8.50
Target Price Low / High 6.00 / 11.00
Median / STD DEV 8.50 / 3.54
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total - Buy Sell
rsi - - -
macd - - -
stoch - - -
ma20 Buy Buy Sell
ma50 - - -
ma100 Sell Buy -
Candlestick PatternFeb. 13, 2023 Hammer - is a candlestick that consists of a small body near the high with a little or no upper shadow and a long lower tail. Considered to be a bullish pattern during a downtrend.
ISIN US02290A1025
ceo Mr. Daniel J. O'Connor J.D.
Website https://ambrx.com
Ambrx Biopharma Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. It focuses on portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications, including ARX517, its proprietary antibody-drug conjugate (ADC) targeting the prostate-specific membrane antigen (PSMA) and ARX788, its proprietary ADC targeting HER2. The company also has preclinical and clinical collaborations with multiple partners on drug candidates using Ambrx technology. The company was incorporated in 2003 and is headquartered in La Jolla, California. As of March 7, 2024, Ambrx Biopharma Inc. operates as a subsidiary of Johnson & Johnson.